TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models

por Schaller, Sophie, Michaud, Magali, Latyszenok, Virginie, Robert, Fabrice, Hocine, Mélanie, Arnoux, Thomas, Gabriac, Mélanie, Codoul, Hélène, Bourhane, Ahmed, de Bellefois, Isabel Clémançon, Afxantidis, Jean, Pruss, Rebecca M
Publicado 2015

Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial

por Le Lamer, Sophie, Paradis, Stéphanie, Rahmouni, Hidayat, Chaimbault, Corinne, Michaud, Magali, Culcasi, Marcel, Afxantidis, Jean, Latreille, Mathilde, Berna, Patrick, Berdeaux, Alain, Pietri, Sylvia, Morin, Didier, Donazzolo, Yves, Abitbol, Jean-Louis, Pruss, Rebacca M, Schaller, Sophie
Publicado 2014